Postnatal Magnesium Trend in less than 34 week Preterms who received Antenatal Neuroprotective Doses of Magnesium Sulphate

Authors

  • M B Sarath Government Health services
  • M R Anand Aster MIMS Calicut
  • Preetha Remesh Aster MIMS Calicut
  • Divia Nath Aster MIMS Calicut
  • Vishnu Mohan Aster MIMS Calicut

DOI:

https://doi.org/10.52314/fnb.2021.v1i2.17

Keywords:

Magnesium Sulphate, Neuroprotection, Magnesium Level

Abstract

Antenatal magnesium sulphate is one of the neuro protective strategies used for preterm deliveries. One of the concerns with this is whether it leads to hypermagnesemia in newborns. Postnatal magnesium levels were studied in 70 preterms whose mothers received magnesium sulphate. No baby had hypermagnesemia. The mean cord blood magnesium level was 2.76 mg/dl which came down to 2.37 mg/dl by 24 hours of life. Babies who needed labour room resuscitation had slightly elevated cord blood magnesium.

Author Biographies

M B Sarath , Government Health services

Consultant Pediatrician

M R Anand , Aster MIMS Calicut

Consultant, Neonatology

Preetha Remesh, Aster MIMS Calicut

Senior Consultant and Head,  Department of Neonatology

Divia Nath, Aster MIMS Calicut

Consultant Neonatology

Vishnu Mohan, Aster MIMS Calicut

Consultant Neonatologist

Published

2021-10-14

How to Cite

1.
Sarath MB, Anand MR, Remesh P, Nath D, Mohan V. Postnatal Magnesium Trend in less than 34 week Preterms who received Antenatal Neuroprotective Doses of Magnesium Sulphate. FNB [Internet]. 2021 Oct. 14 [cited 2021 Oct. 25];1(2):34-7. Available from: https://www.fetusandnewborn.com/journal/index.php/fnb/article/view/17

Issue

Section

Original Research